Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Histopathology|February 22, 2018
Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver diseaseTimothy J Kendall, Grace E Dolman, Catherine M Duff, et al.
The Journal of Pathology. Clinical Research|May 31, 2022
Assessment of clinical trial protocols for pathology content using the SPIRIT-Path guidelines highlights areas for improvementPeter Robinson, Chris M Bacon, Shujing J Lim, et al.
Cancer Research|December 7, 2013
Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinomaRachel V Guest, Luke Boulter, Timothy J Kendall, et al.
The Lancet. Oncology|September 30, 2021
Guidelines for cellular and molecular pathology content in clinical trial protocols: the SPIRIT-Path extensionTimothy J Kendall, Max Robinson, Daniel J Brierley, et al.
JHEP Reports : Innovation in Hepatology|July 17, 2025
Effect of liver biopsy size on MASLD fibrosis assessment by second-harmonic generation/two-photon excitation fluorescence microscopyDaniel T Field, Yayun Ren, Kutbuddin Akbary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2008
The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligationJohn A Conti, Timothy J Kendall, Adrian Bateman, et al.
World Journal of Gastroenterology|August 28, 2024
Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19Angus K Jacobs, Steven D Morley, Kay Samuel, et al.
European Heart Journal|October 23, 2018
The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohortIsabelle D Munsterman, Anthonie L Duijnhouwer, Timothy J Kendall, et al.
Pageof 7